Weight loss effect of glucagon-like peptide-1 mimetics on obese/overweight adults without diabetes: A systematic review and meta-analysis of randomized controlled trials胰高血糖素样肽-1类似物对非糖尿病肥胖/超重成人的减重作用:一篇对随机对照试验进行的系统评价及meta分析
出版年份 2014 全文链接
标题
Weight loss effect of glucagon-like peptide-1 mimetics on obese/overweight adults without diabetes: A systematic review and meta-analysis of randomized controlled trials胰高血糖素样肽-1类似物对非糖尿病肥胖/超重成人的减重作用:一篇对随机对照试验进行的系统评价及meta分析
作者
关键词
-
出版物
Journal of Diabetes
Volume 7, Issue 3, Pages 329-339
出版商
Wiley
发表日期
2014-07-16
DOI
10.1111/1753-0407.12198
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: Differences and similarities
- (2014) Asger Lund et al. European Journal of Internal Medicine
- Glucagon-like peptide-1 receptor agonists for weight loss in adult patients without diabetes
- (2013) A. Ottney AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Effect of GLP-1 Mimetics on Blood Pressure and Relationship to Weight Loss and Glycemia Lowering: Results of a Systematic Meta-Analysis and Meta-Regression
- (2013) M. Katout et al. AMERICAN JOURNAL OF HYPERTENSION
- Comparison of the Hypoglycemic Effect of Acarbose Monotherapy in Patients With Type 2 Diabetes Mellitus Consuming an Eastern or Western Diet: A Systematic Meta-analysis
- (2013) Qibo Zhu et al. CLINICAL THERAPEUTICS
- Benefits of Liraglutide Treatment in Overweight and Obese Older Individuals With Prediabetes
- (2013) S. H. Kim et al. DIABETES CARE
- The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications
- (2013) S. Madsbad DIABETES OBESITY & METABOLISM
- Diagnosis and Management of Prediabetes in the Continuum of Hyperglycemia—When do the Risks of Diabetes Begin? A Consensus Statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists
- (2013) Alan Garber et al. Endocrine Practice
- Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
- (2013) Mojca Jensterle Sever et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
- (2013) T A Wadden et al. INTERNATIONAL JOURNAL OF OBESITY
- Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS
- (2013) L van Bloemendaal et al. JOURNAL OF ENDOCRINOLOGY
- Is there a place for incretin therapies in obesity and prediabetes?
- (2013) Jens Juul Holst et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Exenatide as a Novel Weight Loss Modality in Patients Without Diabetes
- (2012) Jessica L Moreno et al. ANNALS OF PHARMACOTHERAPY
- Effects of Exenatide vs. Metformin on endothelial function in obese patients with pre-diabetes: a randomized trial
- (2012) Aaron S Kelly et al. Cardiovascular Diabetology
- Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme
- (2012) K. Niswender et al. DIABETES OBESITY & METABOLISM
- Liraglutide: short-lived effect on gastric emptying-long lasting effects on body weight
- (2012) J. Jelsing et al. DIABETES OBESITY & METABOLISM
- Effects of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight: A Meta-Analysis
- (2012) Matteo Monami et al. Experimental Diabetes Research
- Impaired Secretion of Total Glucagon-like Peptide-1 in People with Impaired Fasting Glucose Combined Impaired Glucose Tolerance
- (2012) Fang Zhang et al. International Journal of Medical Sciences
- Dysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese Adults
- (2012) Ian J. Neeland et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study
- (2012) Leigh Perreault et al. LANCET
- Rapid Tachyphylaxis of the Glucagon-Like Peptide 1-Induced Deceleration of Gastric Emptying in Humans
- (2011) M. A. Nauck et al. DIABETES
- Short-Term Exenatide Treatment Leads to Significant Weight Loss in a Subset of Obese Women Without Diabetes
- (2011) J. Dushay et al. DIABETES CARE
- Type 2 Diabetes Can Be Prevented With Early Pharmacological Intervention
- (2011) R. A. DeFronzo et al. DIABETES CARE
- Prediabetes: To treat or not to treat?
- (2011) Elisavet Moutzouri et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
- (2011) A Astrup et al. INTERNATIONAL JOURNAL OF OBESITY
- Comparative Effects of the Long-Acting GLP-1 Receptor Ligands, Liraglutide and Exendin-4, on Food Intake and Body Weight Suppression in Rats
- (2011) Matthew R. Hayes et al. Obesity
- Is the GLP-1 system a viable therapeutic target for weight reduction?
- (2011) Jenny Tong et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus
- (2010) Eric A. Schwartz et al. ATHEROSCLEROSIS
- Effects of Exenatide and Lifestyle Modification on Body Weight and Glucose Tolerance in Obese Subjects With and Without Pre-Diabetes
- (2010) J. Rosenstock et al. DIABETES CARE
- Liraglutide for weight loss in obese people – Authors' reply
- (2010) Arne Astrup et al. LANCET
- What is the best treatment for prediabetes?
- (2009) Morali D. Sharma et al. Current Diabetes Reports
- What are the risks and the benefits of current and emerging weight-loss medications?
- (2009) Jamie R. Robinson et al. Current Diabetes Reports
- Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
- (2009) Arne Astrup et al. LANCET
- Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
- (2009) John B Buse et al. LANCET
- Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years
- (2008) David C. Klonoff et al. CURRENT MEDICAL RESEARCH AND OPINION
- Comparison of Single and Combined Treatment with Exenatide and Metformin on Menstrual Cyclicity in Overweight Women with Polycystic Ovary Syndrome
- (2008) Karen Elkind-Hirsch et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started